Zoliflodacin

Kathryn Dzintars, Pharm.D., BCPS

INDICATIONS

FDA

  • Zoliflodacin (Nuzolvence®) is approved for the treatment of uncomplicated urogenital gonorrhea due to Neisseria gonorrhoeae in adults and pediatric patients at least 12 years of age and who weigh at least 35 kg.

There's more to see -- the rest of this topic is available only to subscribers.

© 2000–2026 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.